The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail info@hpra.ie


Tamsulosin 400 micrograms Modified-release Capsules, Hard

400 microgram(s) Capsules Modified Release

McDermott Laboratories Ltd., T/A Gerard LaboratoriesPA0577/073/001

Main Information

Trade NameTamsulosin 400 micrograms Modified-release Capsules, Hard
Active SubstancesTamsulosin hydrochloride
Strength400 microgram(s)
Dosage FormCapsules Modified Release
Licence HolderMcDermott Laboratories Ltd., T/A Gerard Laboratories
Licence NumberPA0577/073/001

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA02 tamsulosin

Status

Authorised/WithdrawnAuthorised
Licence Issued24/03/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of Licence
Marketing StatusMarketed

Documents

Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0024-066-044
Interchangeable List DocumentPDF of Interchangeable List
« Back